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Abstract
Leukemia inhibitory factor (LIF), interleukin 6 (IL-6) and IL-8 are important regulators of inflammation and
hematopoiesis. Human bone marrow stromal cells regulate marrow hematopoiesis by secreting cytokines. By using reverse-
transcriptase polymerase chain reaction (RT-PCR), we demonstrate that human bone marrow stromal cells constitutively
express LIF, IL-6 and IL-8 transcripts. By using specific ELISAs, we found that their spontaneous productions of LIF, IL-6
and IL-8 are elevated in response to serum and after stimulation with the pro-inflammatory cytokines IL-1K and TNF-K. The
anti-inflammatory cytokine IL-4 reduces their serum- and cytokine-induced LIF secretion. By contrast, IL-4 stimulates their
serum- and IL-1K-induced IL-6 synthesis. IL-4 has no effect on the serum-induced IL-8 synthesis by marrow stromal cells,
but stimulates their cytokine-induced IL-8 production. The anti-inflammatory cytokine IL-10 has no effect on the serum- and
cytokine-induced LIF, IL-6 and IL-8 synthesis by bone marrow stromal cells. RT-PCR experiments reveal the presence of
IL-4 receptor K-chain mRNA and IL-10 receptor mRNA in cultured bone marrow stromal cells. The differential regulation
by IL-4 of two related cytokines, such as LIF and IL-6, and the enhanced effect of this ‘anti-inflammatory’ cytokine on IL-6
and IL-8 synthesis highlight the tightly controlled regulation and the complexity of the cytokine production within the
human bone marrow. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Long-term bone marrow culture methods are char-
acterized by the development of an adherent cell
layer (mostly ¢broblast-like cells) producing various
cytokines anchored to cell membranes and/or re-
leased in the culture medium. These compounds in-
teract together and are essential for the development
of in vitro hematopoiesis [1,2]. Thus, bone marrow
stromal cells regulate hematopoiesis by interacting
directly (cell-to-cell contact) with hematopoietic cells
and by secreting cytokines that modulate hematopoi-
esis either in a positive or a negative manner.
Human bone marrow stromal cells secrete numer-
ous cytokines including leukemia inhibitory factor
(LIF), interleukin 6 (IL-6) and IL-8 [3^5]. LIF is a
pleiotropic cytokine identi¢ed by its growth and dif-
ferentiation activities on hematopoietic cells [6^8].
LIF shares with IL-6 biological activities [9,10] and
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receptor components [11]. LIF promotes the survival
and/or proliferation of primitive hematopoietic pre-
cursors [8,12]. IL-6 supports, in synergy with macro-
phage colony-stimulating factor, the formation of
macrophage colonies from marrow progenitors [13].
IL-6, through a paracrine mechanism, is the major
cytokine involved in the emergence of the tumor
clone in patients with multiple myeloma [14]. IL-8
is reported to inhibit the growth of isolated CD34
stem/progenitor cells [15,16] and its intravenous in-
jection induces a rapid mobilization of hematopoietic
progenitor cells in rhesus monkeys [17].
Human bone marrow stromal cells produce LIF,
IL-6 and IL-8 spontaneously, in response to serum
and monocyte-derived cytokines such as IL-1K and
TNF-K [3^5]. Conversely, no result is available con-
cerning cytokines that down-regulate their LIF, IL-6
and IL-8 synthesis. IL-4 and IL-10 are classi¢ed as
anti-in£ammatory cytokines on the basis of their in-
hibitory e¡ects on the production of several cyto-
kines (including IL-6, IL-8 and LIF) from various
cell types [18^22]. In this study we have investigated
the e¡ects of IL-4 and IL-10 on the spontaneous,
serum- and cytokine-induced LIF, IL-6 and IL-8
production by human bone marrow stromal cells in
vitro.
2. Materials and methods
2.1. Human bone marrow stromal cell cultures
Cultures of human bone marrow stromal cells
were established from bone marrow aspirates har-
vested into heparinized tubes (Vacutainer system,
Becton Dickinson, Meylan, France) and considered
as normal by morphological analysis of the May
Grunwald Giemsa stained smears. The procedure
was performed according to the Helsinki recommen-
dations on patients undergoing a myelogram as part
of routine procedure. Mononuclear cells were sepa-
rated on a Ficoll gradient (400Ug, 20 min), washed
two times with Hanks’ balanced salts solution
(400Ug, 10 min), and seeded in culture £asks in
RPMI 1640 with 20% FCS, penicillin (100 U/ml)
and streptomycin (100 Wg/ml) at 37‡C in 5% CO2
in air [23]. Adherent cells were grown to con£uence
for 5^8 weeks with weekly changes of medium and
were subcultured after trypsin treatment. As previ-
ously reported [4], in these experimental conditions,
more than 99.8% of cells were CD23 and CD223
indicating the absence of T- and B-cells on the layers
and 4% of cells were CD14 and CD33 indicating a
monocytic lineage.
2.2. Cell stimulation
Human bone marrow stromal cells were used at
their ¢rst passage. Cells (1U104 per well) were plated
for 24 h in 96-well plates in 100 Wl of RPMI 1640
with 20% FCS. Adherent cells were washed and
200 Wl of serum-free medium was added to each
well for 2 days. After washing, several experimental
conditions were used to investigate bone marrow
stromal cell cytokine production. In the ¢rst set of
experiments, cells were reactivated with 200 Wl of
RPMI 1640 with 10% FCS and stimulated with IL-
1K (10 ng/ml) (Tebu, Le Perray en Yvelines, France),
TNF-K (10 ng/ml) (Tebu), IL-4 (10 ng/ml) (Shering
Plough), IL-10 (10 U/ml) (a gift from Dr. J.C. Le-
cron, Poitiers, France) or IL-4 (10 ng/ml)+IL-10
(10 U/ml). Media were collected after 2, 4 or 7 days
of growth and stored at 380‡C until LIF, IL-6 and
IL-8 assay. No signi¢cant level of endotoxin was
found into FCS assessed by Limulus test (E-Toxate
kit, Sigma). In another set of experiments, cells were
reactivated with 200 Wl of serum-free RPMI 1640 and
stimulated with IL-1K (0.1^100 ng/ml), TNF-K (0.1^
100 ng/ml), IL-4 (0.1^100 ng/ml), and IL-10 (0.1^
300 U/ml). After 24 h, media were collected and
stored at 380‡C until LIF, IL-6 and IL-8 assay. In
another set of experiments, stimulations with IL-1K
(100 ng/ml), TNF-K (100 ng/ml), IL-1K (100 ng/
ml)+TNF-K (100 ng/ml), IL-1K (100 ng/ml)+IL-4
(1 to 100 ng/ml), TNF-K (100 ng/ml)+IL-4 (1^100
ng/ml), IL-1K (100 ng/ml)+IL-10 (1^100 U/ml) or
TNF-K (100 ng/ml)+IL-10 (1^100 U/ml) were made
with 0% FCS in the culture medium. After 24 h,
media were collected and stored at 380‡C until
LIF, IL-6 and IL-8 assay.
2.3. Measurements of LIF, IL-6 and IL-8 levels
LIF levels were measured by an enzyme-linked im-
munosorbent assays (ELISA) for human LIF as pre-
viously described [24]. IL-6 and IL-8 levels were
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measured by a ‘sandwich-type’ ELISA (Pelikine com-
pact human ELISA Kit, Tebu, France) following the
manufacturer’s instructions. The sensitivity of the
assays enables the detection of levels as low as
2 pg/ml for IL-6 and IL-8 and 12 pg/ml for LIF.
No signi¢cant cross-reactivity of the three ELISA
was observed with the various cytokines used in
this study to stimulate marrow stromal cells.
2.4. RT-PCR analysis of LIF, IL-6 and IL-8
transcripts
Human marrow stromal cells (1U106) were plated
for 24 h in 25-cm2 culture £asks in 5 ml of RPMI
1640 with 20% FCS. Adherent cells were then
washed and 5 ml of serum-free medium were added
to each £ask for 3 days. Total RNA was then ex-
tracted with RNA NOW reagent (Biogentex, Ozyme,
France) following the manufacturer’s instructions.
The ¢rst cDNA strand was synthesized using total
RNA (2 Wg) at 45‡C for 30 min in a 100 Wl reaction
mixture containing 50 mM Tris-HCl (pH 8.3), 60
mM KCl, 10 mM dithiothreitol (DTT), 5 mM
MgCl2, 20 U of RNase inhibitor (Boehringer, Mann-
heim, Germany), 1 mM of each deoxynucleotide tri-
phosphate (dNTP), 600 U of M-MLV reverse tran-
scriptase (Gibco) and 2 Wg of oligo(dT) 15 mer. One
Wg of the reaction mixture was made up to 25 Wl
using Taq polymerase bu¡er (10 mM Tris-HCl pH
8.3, 50 mM KCl, 1.5 mM MgCl2) containing
10 pmol of each primer and 0.6 U of AmpliTaq
DNA polymerase (Pharmacia Biotech, Uppsala,
Sweden). Ampli¢cations were performed using a
thermal cycler for 35 cycles under the following con-
ditions: denaturation for 1 min at 94‡C, annealing
for 45 s at 59‡C and elongation for 1 min at 72‡C
using IL-8 primers: sense, 5P-TGGCTCTCTTGGC-
AGCCTTC and antisense, 5P-TCTCCACAACCCT-
CTGCACC; IL-6 primers: sense, 5P-TGGTGTTG-
CCTGCTGCCTTC and antisense, 5P-CTCATCTG-
CACAGCTCTGGC; LIF primers: sense, 5P-CCCT-
GCTGTTGGTTCTGCAC and antisense, 5P-CCAA-
CACGCCGATGATCTGC. PCR products were sep-
arated in a 1% agarose gel and analyzed by ethidium
bromide staining. Control PCR was performed using
L-actin primers: 5P-GGCTACAGCTTCACCACC-
AC and antisense: 5P-GCACTGTGTTGGCGTAC-
AGG to check RNA integrity.
2.5. RT-PCR analysis of IL-4 receptor K-chain
(IL-4RK) and IL-10R transcripts
Total RNA was extracted from bone marrow stro-
mal cell cultures as reported above. RNA was re-
verse-transcribed as previously reported [25]. cDNA
was boiled 5 min, quenched on ice and diluted with
80 Wl of distilled water before PCR ampli¢cation. A
10-Wl aliquot of the diluted cDNA mixture was am-
pli¢ed by PCR using recombinant Taq polymerase
under the following conditions: 1 min, 94‡C; 1 min,
53‡C; 1.5 min, 72‡C for 30 cycles. PCR reaction was
performed in a total volume of 50 Wl containing
75 mM of Tris-HCl (pH 9.0), 20 mM of (NH4)2SO4,
0.01% of Tween 20, 1.5 mM of MgCl2, 0.4 mM of
each of dNTP, 0.15 WM of the two IL-4RK, IL-10 or
L-actin PCR primers, and 0.1 U/ml of DNA poly-
merase (Eurogentec, Belgium). The human IL-4RK
chain sense primer was 5P-GGAAGAGGGGTA-
TAAGCCTTT-3P and the antisense primer was 5P-
CACGGAGACAAAGTTCACGAT-3P spanning a
571-bp fragment [26]. The human IL-10R sense
primer was 5P-CCATCTTGCTGACAACTTCC-3P
and the antisense primer was 5P-GTGTCTGATAC-
TGTCTTGGC-3P spanning a 439-bp fragment [27].
The L-actin sense primer was 5P-GAGACCTTCAA-
CAACCC-3 and the antisense primer was 5P-GT-
GGTGGTGAAGCTGTAGCC-3P spanning a 235-
bp fragment [25]. PCR products were electropho-
resed in a 2% agarose gel (Gibco) and visualized by
ethidium bromide staining.
2.6. Statistical analysis
Results are presented as mean þ S.E.M. of four
independent experiments. Di¡erences between cyto-
kine-treated groups and control groups were com-
pared with the Mann^Whitney U-test. P6 0.05 was
considered to be signi¢cant.
3. Results
3.1. Presence of LIF, IL-6 and IL-8 transcripts in
marrow stromal cells
As shown in Fig. 1, by using RT-PCR, we dem-
onstrated that LIF, IL-6 and IL-8 transcripts were
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constitutively expressed in 11/12, 12/12 and 12/12 of
the di¡erent human marrow stromal layers, respec-
tively (data not shown).
3.2. E¡ects of cytokines on the production of LIF,
IL-6 and IL-8 by bone marrow stromal cells
cultured in serum-supplemented medium
In accordance with their constitutive expression of
LIF, IL-6 and IL-8 transcripts, marrow stromal cells
cultured for 24 h in serum-free medium secreted LIF,
IL-6 and IL-8 proteins in their culture supernatants
(Table 1). These productions of LIF, IL-6 and IL-8
were signi¢cantly (P6 0.05) higher in serum-contain-
ing medium than in serum-free medium (Table 1).
TNF-K (10 ng/ml) and IL-1K (10 ng/ml) enhanced
in a time-dependent manner the production of LIF,
IL-6 and IL-8 (Fig. 2A, B and C, respectively) by
bone marrow stromal cells cultured in 10% FCS.
IL-4 (10 ng/ml) signi¢cantly decreased their LIF se-
cretion (Fig. 3A), increased their IL-6 production
(Fig. 3B) and had no e¡ect on their IL-8 synthesis
(Fig. 3C). IL-10 (10 U/ml) had no e¡ect on LIF, IL-6
and IL-8 secretions (Fig. 3A, B and C, respectively).
When added to IL-4 (10 ng/ml), IL-10 (10 U/ml) did
not modify the e¡ect of IL-4 alone (data not shown).
In these experiments, IL-1K, TNF-K and IL-4 did
not change cell growth (data not shown).
3.3. E¡ect of cytokines on the production of LIF,
IL-6 and IL-8 by bone marrow stromal cells
cultured in serum-free medium
Since FCS contained factors that stimulated LIF,
IL-6 and IL-8 secretion by bone marrow stromal
cells, we focused on the serum-free medium condi-
tion for the remainder of the experiments. As shown
in Fig. 4A, IL-1K and TNF-K stimulated, in a dose-
dependent manner, LIF secretion by human bone
marrow stromal cells. In contrast, IL-4 and IL-10
had no e¡ect. As shown in Table 2, the stimulatory
e¡ects of IL-1K (100 ng/ml) and TNF-K (100 ng/ml)
on LIF production were additive. As shown in Fig.
4B, IL-1K, TNF-K and IL-4 stimulated, in a dose-
dependent manner, IL-6 secretion by bone marrow
stromal cells. The highest IL-10 tested concentration
(100 U/ml) had a weak enhanced e¡ect on their IL-6
secretion. As reported in Table 2, the co-addition of
Fig. 1. Analysis of LIF, IL-6 and IL-8 transcripts in bone marrow stromal cells. Total RNA isolated from human bone marrow stro-
mal cells were submitted to RT-PCR as described in Section 2 and ampli¢cation products were submitted to agarose gel electrophore-
sis and ethidium bromide staining. Lanes 2, 6 and 10, LIF transcripts (size of 575 bp) from three di¡erent bone marrow stromal cell
samples; lanes 3, 7 and 11, IL-6 transcripts (size of 380 bp) from three di¡erent cell samples; lanes 4, 8, and 12, IL-8 transcripts (size
of 250 bp) from three di¡erent cell samples; lanes 5, 9 and 13, L-actin transcripts (size of 310 bp) from three di¡erent cell samples;
lanes 1 and 14, 1-kb DNA ladder.
Table 1
Secretion of LIF, IL-6 and IL-8 by human bone marrow stro-
mal cells
0% FCS 10% FCS
LIF (pg/ml) 47 þ 15 565 þ 129a
IL-6 (pg/ml) 80 þ 10 1500 þ 810a
IL-8 (pg/ml) 45 þ 25 408 þ 144a
Cells (1U104) were cultured for 24 h in medium with 0 or 10%
FCS. LIF, IL-6 and IL-8 were measured by ELISA and are ex-
pressed as mean þ S.E.M. of four independent experiments.
aP6 0.05 as compared to 0% FCS (Mann^Whitney U-test).
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Fig. 2. Kinetics of LIF (A), IL-6 (B) and IL-8 (C) secretion by
human bone marrow stromal cells in response to IL-1K and
TNF-K. Cells (1U104) were grown in medium with 10% FCS
in the absence (control) or the presence of IL-1K (10 ng/ml) or
TNF-K (10 ng/ml). At various times, supernatants were har-
vested and assayed for LIF, IL-6 or IL-8. Mean þ S.E.M. of
four experiments. *P6 0.05 as compared to controls (Mann^
Whitney U-test).
Fig. 3. Kinetics of LIF (A), IL-6 (B) and IL-8 (C) secretion hu-
man bone marrow stromal cells in response to IL-4 and IL-10.
Cells (1U104) were grown in medium with 10% FCS in the ab-
sence (control) or the presence of IL-4 (10 ng/ml) or IL-10
(10 U/ml). At various times, supernatants were harvested and
assayed for LIF, IL-6 or IL-8. Mean þ S.E.M. of four experi-
ments. *P6 0.05 as compared to controls (Mann^Whitney
U-test).
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IL-1K (100 ng/ml) and TNF-K (100 ng/ml) gave a
greater than additive increase for the induction of
IL-6 (P6 0.05, Mann^Whitney U-test) suggesting a
synergistic e¡ect. As shown in Fig. 4C, IL-1K and
TNF-K stimulated IL-8 secretion in serum-free con-
ditions. The highest IL-4 (100 ng/ml) and IL-10
(100 U/ml) tested concentrations had a weak en-
hanced e¡ect on the IL-8 secretion. As reported in
Table 2, the co-addition of IL-1K (100 ng/ml) and
TNF-K (100 ng/ml) gave a greater than additive in-
crease for the induction of IL-8 (P6 0.05, Mann^
Whitney U-test) suggesting a synergistic e¡ect.
3.4. E¡ect of IL-4 and IL-10 on IL-1K- and
TNF-K-induced production of LIF, IL-6 and
IL-8 by bone marrow stromal cells
We next assessed the e¡ects of various concentra-
tions of IL-4 and IL-10 on the TNF-K- and IL-1K-
induced LIF, IL-6 and IL-8 secretion by marrow
stromal cells cultured in serum-free medium. As
shown in Fig. 5A, IL-4 (10 ng/ml) signi¢cantly
(P6 0.05) reduced by 50% and 68% the LIF secre-
tion by cells stimulated with TNF-K and IL-1K, re-
spectively. In contrast, IL-4 (100 ng/ml) increased by
3.9-fold their IL-6 production in response to IL-1K
(Fig. 5B). Finally, IL-4 (100 ng/ml) enhanced the
IL-8 secretion by TNF-K and IL-1K-stimulated mar-
row stromal cells by 1.8- and 4.5-fold, respectively
(Fig. 5C). In similar experimental conditions, IL-10
(1^100 U/ml) had no signi¢cant (Ps 0.1) e¡ect on
the LIF, IL-6 or IL-8 production by cytokine-stimu-
Fig. 4. Dose-dependent e¡ect of IL-1K, TNF-K, IL-4 and IL-10
on LIF (A), IL-6 (B) and IL-8 (C) secretion by human bone
marrow stromal cells. Cells (1U104) were stimulated for 24 h in
serum-free medium. Mean þ S.E.M. of four experiments.
*P6 0.05 as compared to controls (Mann^Whitney U-test).
Table 2
Secretion of LIF, IL-6 and IL-8 by IL-1K- and TNF-K-stimu-
lated human bone marrow stromal cells
LIF (ng/ml) IL-6 (ng/ml) IL-8 (ng/ml)
Controls 0.06 þ 0.02 0.08 þ 0.01 0.02 þ 0.00
IL-1K 1.20 þ 0.13 2.68 þ 0.61 2.70 þ 0.90
TNF-K 0.69 þ 0.07 1.21 þ 0.15 4.70 þ 0.15
IL-1K+TNF-K 2.03 þ 0.5 14.25 þ 2.40a 20.36 þ 5.33a
Cells (1U104) were cultured for 24 h in serum-free medium in
the absence or presence of IL-1K (100 ng/ml) and TNF-K
(100 ng/ml) or a combination of IL-1K and TNF-K. LIF, IL-6
and IL-8 were measured by ELISA and are expressed as
mean þ S.E.M. of three independent experiments.
aP6 0.05 (Mann^Whitney U-test) as compared with the sum of
the e¡ect of IL-1K alone and TNF-K alone.
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lated human bone marrow stromal cells (data not
shown).
3.5. Presence of IL-4RK and IL-10R transcripts in
marrow stromal cells
Because the lack of e¡ect of IL-10 on bone mar-
row stromal cells might be related to the absence of
IL-10R, we studied the expression of IL-10R mRNA
in these cells. As shown in Fig. 6, RT-PCR experi-
ments reveal the presence of IL-10R mRNA and IL-
4RK chain mRNA in human bone marrow stromal
cells and in blood mononuclear cells used as a pos-
itive control.
4. Discussion
LIF, IL-6 and IL-8 are important regulators of
marrow hematopoiesis [8^17]. While in£ammatory
cytokines stimulate human bone marrow stromal
cells to produce LIF, IL-6 and IL-8 [3^5,28], no re-
sult has highlighted cytokines that reduce their syn-
thesis. To further our understanding of the regula-
tion of LIF, IL-6 and IL-8 synthesis in the bone
marrow, we have investigated the e¡ect of the two
anti-in£ammatory cytokines IL-4 and IL-10 on the
serum- and cytokine-induced LIF, IL-6 and IL-8
production by human bone marrow stromal cells.
Human bone marrow stromal cells constitutively
express LIF, IL-6 and IL-8 transcripts and enhanced
their LIF, IL-6 and IL-8 secretions in response to
serum and in£ammatory cytokines, such as TNF-K
and IL-1K. IL-4 markedly reduces their serum- and
cytokine-induced LIF production. Our results, that
agree with a previous study reporting that IL-4 de-
creases the LIF synthesis from long-term adherent
layer cultures grown in serum [28], show that IL-4
acts on marrow ¢broblast-like cells, the major com-
ponent of the long-term bone marrow culture. In
contrast to IL-4, IL-10 does not change their serum-
and cytokine-induced LIF synthesis. This di¡erential
e¡ect of IL-4 and IL-10 on LIF synthesis is similar to
that found in isolated human synoviocytes (another
local stromal cell population) [21].
IL-10 does not change the serum- and cytokine-
induced IL-6 production by human bone marrow
stromal cells. While IL-4 reduces marrow stromal
Fig. 5. E¡ects of IL-4 on TNF-K- or IL-1K-induced LIF (A),
IL-6 (B) and IL-8 (C) secretion by human bone marrow stro-
mal cells. Cells (1U104) were stimulated for 24 h in serum-free
medium by TNF-K (100 ng/ml) or IL-1K (100 ng/ml) in the ab-
sence or presence of the indicated IL-4 concentrations. Mean þ
S.E.M. of four experiments. *P6 0.05 as compared to controls
(Mann^Whitney U-test).
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cell LIF synthesis, it markedly stimulates their IL-6
production in response to serum and IL-1K. This
dichotomy between IL-6 and LIF synthesis in re-
sponse to IL-4 was already reported for human syn-
oviocytes [21]. Moreover, as for human bone marrow
stromal cells, IL-4, but not IL-10, is found to stim-
ulate human synoviocytes IL-6 secretion [29]. The
similarities between bone marrow stromal cells and
synoviocytes concerning the regulation of their LIF
and IL-6 production in response to TNF-K, IL-1K,
IL-4 and IL-10 might be related to their ¢broblast-
like cell status.
Similarly to that observed for LIF and IL-6 syn-
thesis, IL-10 has no signi¢cant e¡ect on IL-8 produc-
tion by bone marrow stromal cells. This later result is
consistent with the absence of IL-10 e¡ect on the
synthesis of IL-8 by pulmonary stromal cell popula-
tions [30], skin and synovial ¢broblasts [31]. While
IL-4 does not change the serum-induced secretion of
IL-8 by marrow stromal cells, it stimulates their IL-8
synthesis in response to TNF-K and IL-1K. IL-4 is
reported to stimulate IL-8 synthesis by endotoxin-
stimulated endothelial cells [32]. However, opposite
results have been found [33].
Cultured bone marrow stromal cells and marrow
stromal cell lines express LIF, IL-6 and IL-8 mRNA
[3^5,34,35]. In contrast, Cluitmans et al. [36] have
documented that LIF and IL-8 mRNA are not
present in bone marrow biopsy specimens from the
iliac crest of normal healthy individuals suggesting
that LIF and IL-8 are not expressed by bone marrow
stromal cells in steady-state condition. The pattern of
cytokine production from cultured bone marrow
stromal cells and cells inside marrow biopsy speci-
mens might be di¡erent due to new cellular interac-
tions during the development of the bone marrow
stromal cell layer in vitro. For example, data have
reported that freshly isolated monocytes are rapidly
induced to produce IL-8 mRNA and protein by ad-
herence to plastic [37]. Alternatively, it might also be
suggested that, in the study of Cluitmans et al. [36],
the LIF and IL-8 mRNA levels in marrow biopsy
specimens are below their detection limit. Clearly,
further studies are required to ensure these discrep-
Fig. 6. IL-4RK chain and IL-10R mRNA expression by human bone marrow stromal cells by RT-PCR. Lane 1, 100-bp DNA size
ladder; lane 2, L-actin blank; lane 3, IL-4RK (or IL-10R) blank; lane 4, L-actin from blood mononuclear cells ; lane 5, IL-4RK (or
IL-10R) from blood mononuclear cells ; lanes 6, 8 and 10, L-actin from three di¡erent marrow stromal cell cultures; lanes 7, 9 and
11, IL-4RK (or IL-10R) from three di¡erent marrow stromal cell cultures. The size of the PCR products is indicated with arrows.
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ancies and the molecular signals mediating the pos-
itive e¡ect of IL-4 on IL-6 and IL-8 secretion by
cultured bone marrow stromal cells and its negative
e¡ect on their LIF synthesis.
Human bone marrow stromal cells express IL-4RK
chain transcripts and IL-4 modulates their LIF, IL-6
and IL-8 secretions suggesting the presence of func-
tional IL-4R on human bone marrow stromal cells.
By contrast, despite the presence of IL-10R mRNA
in human bone marrow stromal cells, IL-10 has no
e¡ect on their LIF, IL-6 and IL-8 secretion. It could,
thus, be argued that the high sensitivity of the
RT-PCR procedure might reveal levels of mRNA
expression that could be physiologically irrelevant
and that the presence of IL-10R mRNA does not
implicate the production of a functional membrane
IL-10R.
In summary, human bone marrow stromal cells
produce LIF, IL-6 and IL-8 in response to serum
or in£ammatory cytokines. IL-4, but not IL-10, re-
duces their serum- and cytokine-induced LIF synthe-
sis. Conversely, IL-4, but not IL-10 increases their
IL-6 and IL-8 production. The di¡erential regulation
by IL-4 of two related cytokines, such as LIF and
IL-6, highlights the tightly controlled regulation of
cytokine productions within the human bone mar-
row. These results are the basis for future investiga-
tions examining the consequences of IL-4-mediated
inhibition of LIF and stimulation of IL-6 and IL-8
expression on marrow hematopoiesis. We suggest
that IL-4, by increasing bone marrow IL-6 and IL-
8 concentrations, might lead to the selective recruit-
ment of cells, such as monocytes/macrophages and
T-lymphocytes, contributing to the progression and/
or resolution of the in£ammatory response and im-
mune reaction.
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